Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
May 1, 2026, 9:30 AM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 11.87 million as of May 1, 2026. Its market cap has decreased by -13.90% in one year.
Market Cap
11.87M
Enterprise Value
14.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 11.87M, a decrease of -75.72%. That is a compound annual growth rate of -11.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 11.87M | -32.47% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 15.79M |
| Britannia Life Sciences | 14.60M |
| Rapid Dose Therapeutics | 12.96M |
| Innovotech | 11.98M |
| PreveCeutical Medical | 11.96M |
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 8.65M |
| COSCIENS Biopharma | 8.25M |